Key result
Addition of a pharmacist to the pulmonary embolism response team significantly reduced median time to thrombolytic administration compared to the pre-intervention group (23 vs 54 minutes; p=0.007).
Why the study?
Literature surrounding the impact of pharmacist inclusion in pulmonary embolism response teams (PERT) is limited, and its effect on time to systemic thrombolysis was unknown.
Does the addition of a pharmacist to a pulmonary embolism response team reduce time to systemic thrombolysis administration in patients with submassive or massive PE?
Observational (n=34)
No
Does the addition of a pharmacist to a pulmonary embolism response team reduce time to systemic thrombolysis administration in patients with submassive or massive PE?
Absolute Event Rate: 23% vs 54%
p-value: p=0.007
The inclusion of a pharmacist in a pulmonary embolism response team significantly reduces the order-to-needle time for systemic thrombolysis in appropriate PE candidates.
Pharmacist addition to PERT was associated with faster thrombolysis; leaves open whether routine inclusion improves PE outcomes.
Introduction Pulmonary embolism (PE) is the third most common cause of cardiovascular death in the United States. Institutions have implemented pulmonary embolism response teams (PERT) to hasten clinical decision making and therapeutic interventions. The extent to which critical care pharmacists are included in PERTs is not known. Although improved outcomes with pharmacist involvement in other emergency response teams (e.g., stroke teams) is well described, literature surrounding the impact of pharmacist inclusion in PERTs is limited. The objective was to evaluate if direct pharmacist inclusion in a PERT resulted in reduced time to systemic thrombolysis from time of medication order release in appropriate PE candidates. Methods This was a retrospective, observational study of patients with submassive or massive PE who received systemic thrombolysis at a large academic medical center. Patients were divided into two groups based on if they received systemic thrombolysis before or after the intervention. This intervention was the addition of a pharmacist to the PERT with emphasis on early communication between the PERT pharmacist and other stakeholders at time of PERT activation, and a revised thrombolytic preparation workflow emphasizing bedside preparation by the pharmacist. The primary outcome was time to administration of thrombolytic from time of medication order release. Results Thirty‐four patients were included. Median time to thrombolytic administration was reduced in the post‐intervention group compared to the pre‐intervention group (23 min [14.8–42] vs. 54 min [42.8–69], p = 0.007). Bleeding events were not different between groups. Time to resumption of systemic anticoagulation after systemic thrombolysis was greater in the post‐intervention group. Conclusion Inclusion of a pharmacist in the PERT at this institution significantly reduced time to administration of systemic thrombolysis from time of medication order release in appropriate PE candidates. Larger studies should be conducted to expand upon and confirm these findings.
No takes yet. Share an insight, caveat, or question.
Berdahl et al. (2023) conducted an observational in Submassive or massive pulmonary embolism (n=34). Addition of a pharmacist to the pulmonary embolism response team (PERT) vs. Pre-intervention (no pharmacist in PERT) was evaluated on Time to administration of thrombolytic from time of medication order release (p=0.007). Addition of a pharmacist to the pulmonary embolism response team significantly reduced median time to thrombolytic administration compared to the pre-intervention group (23 vs 54 minutes; p=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: